Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reproductive Health
Published in: Reproductive Health 1/2021

Open Access 01-12-2021 | Fertility | Research

'Does HPV affect my fertility?' Reproductive concerns of HPV-positive women: a qualitative study

Authors: Kowsar Qaderi, Seyedeh Tahereh Mirmolaei, Mehrnaz Geranmayeh, Farnaz Farnam, Shahrzad Sheikh Hasani

Published in: Reproductive Health | Issue 1/2021

Login to get access

Abstract

Background

Reproductive health changes can occur following infection with Human papillomavirus. HPV is the most prevalent sexually transmitted infection causing a variety of clinical manifestations ranging from warts to cancer. This study aimed to explore the reproductive concerns of women infected with HPV.

Methods

In this qualitative study, we used the conventional content analysis approach, with the aid of MAXQDA.10 software, to analyze data extracted from the face-to-face semi-structured interviews with 20 Iranian HPV-positive women (sampled by maximum variation purposive sampling). The accuracy of this research was ensured according to the four criteria proposed by Guba and Lincoln.

Results

Exploring participants' reproductive concerns, three main categories were identified from the interviews including concerns about fertility potential, pregnancy and non-pregnancy reproductive issues. HPV-positive women concerned about reduced female/ male fertility due to HPV, the impact of the HPV on the fetal health, adverse pregnancy outcomes such as miscarriage and preterm delivery, and mother-to-child transmission of HPV during breastfeeding. HPV-positive women with abnormal cytology results were anxious that becoming pregnant or taking hormonal contraception might worsen their abnormalities. Most married women were reluctant to use a condom. Participants requested further information about the potential reproductive risks of the HPV vaccine. They also wanted to know about the safety of HPV vaccine during pregnancy and breastfeeding.

Conclusions

HPV-positive women had some reproductive concerns that should be considered in the designing of educational-consulting interventions. Women need to be better understood and informed about the impact of HPV on their reproductive health. Health care providers may lack knowledge about these specific areas, and they could benefit from additional up-to-date information to address women's reproductive concerns.
Appendix
Available only for authorised users
Literature
1.
Centre IIHI. Iran: human papillomavirus and related cancers, fact sheet. 2018. ICO/IARC HPV Information Centre, 2018.
2.
3.
4.
Xiong YQ, Chen YX, Cheng MJ, He WQ, Chen Q. The risk of human papillomavirus infection for male fertility abnormality: a meta-analysis. Asian J Androl. 2018;20(5):493–7.PubMedPubMedCentralCrossRef
5.
Capra G, Schillaci R, Bosco L, Roccheri MC, Perino A, Ragusa MA. HPV infection in semen: results from a new molecular approach. Epidemiol Infect. 2019;147:PubMedPubMedCentralCrossRef
6.
Merckx M, Liesbeth W-VW, Arbyn M, Meys J, Weyers S, Temmerman M, et al. Transmission of carcinogenic human papillomavirus types from mother to child: a meta-analysis of published studies. Eur J Cancer Prev. 2013;22(3):277–85.PubMedCrossRef
7.
Nohr B, Kjaer SK, Soylu L, Jensen A. High-risk human papillomavirus infection in female and subsequent risk of infertility: a population-based cohort study. Fertil Steril. 2019;111(6):1236–42.PubMedCrossRef
8.
9.
Ambühl LM, Baandrup U, Dybkær K, Blaakær J, Uldbjerg N, Sørensen S. Human papillomavirus infection as a possible cause of spontaneous abortion and spontaneous preterm delivery. Infect Dis Obstet Gynecol. 2016;2016:3086036.PubMedPubMedCentralCrossRef
10.
Perino A, Giovannelli L, Schillaci R, Ruvolo G, Fiorentino FP, Alimondi P, et al. Human papillomavirus infection in couples undergoing in vitro fertilization procedures: impact on reproductive outcomes. Fertil Steril. 2011;95(5):1845–8.PubMedCrossRef
11.
Spandorfer SD, Bongiovanni AM, Fasioulotis S, Rosenwaks Z, Ledger WJ, Witkin SS. Prevalence of cervical human papillomavirus in women undergoing in vitro fertilization and association with outcome. Fertil Steril. 2006;86(3):765–7.PubMedCrossRef
12.
Pandey D, Solleti V, Jain G. Human papillomavirus (HPV) infection in early pregnancy: prevalence and implications. Infect Dis Obstetr Gynecol. 2019;2019:4376902.
13.
Andía D, Mozode Rosales F, Villasante A, Rivero B, Díez J, Pérez C. Pregnancy outcome in patients treated with cervical conization for cervical intraepithelial neoplasia. Int J Gynecol Obstetr. 2011;112(3):225–8.CrossRef
14.
Ehsanipoor RM, Jolley JA, Goldshore MA, Szymanski LM, Haydon ML, Gaffaney CL, et al. The relationship between previous treatment for cervical dysplasia and preterm delivery in twin gestations. J Maternal-Fetal Neonatal Med. 2014;27(8):821–4.CrossRef
15.
Hernández-Girón C, Smith JS, Lorincz A, Lazcano E, Hernández-Avila M, Salmerón J. High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in Mexico. Sex Transm Dis. 2005;32(10):613–8.PubMedCrossRef
16.
Volpato LK, Siqueira IR, Nunes RD, Piovezan AP. Association between hormonal contraception and injuries induced by human papillomavirus in the uterine cervix. Revista Brasileira Ginecologia Obstetricia. 2018;40(4):196–202.CrossRef
17.
Tseng CJ, Liang CC, Soong YK, Pao CC. Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery. Obstetr Gynecol. 1998;91(1):92–6.CrossRef
18.
Skoczyński M, Goździcka-Józefiak A, Kwaśniewska A. Co-occurrence of human papillomavirus (HPV) in newborns and their parents. BMC Infect Dis. 2019;19(1):930.PubMedPubMedCentralCrossRef
19.
Pradhan SR, Mahata S, Ghosh D, Sahoo PK, Sarkar S, Pal R, et al. Human papilloma virus infections in pregnant women and its impact on pregnancy outcomes: possible mechanism of self-clearance. Human Papillomavirus: IntechOpen; 2020.
20.
Bennett KF. The psychosexual impact of testing positive for high-risk cervical human papillomavirus (HPV): a systematic review. Turk J Obstet Gynecol. 2019;28(10):1959–70.
21.
Perrin KK, Daley EM, Naoom SF, Packing-Ebuen JL, Rayko HL, McFarlane M, et al. Women’s reactions to HPV diagnosis: insights from in-depth interviews. Women Health. 2006;43(2):93–110.PubMedCrossRef
22.
Kosenko KA, Hurley RJ, Harvey JA. Sources of the uncertainty experienced by women with HPV. Qual Health Res. 2012;22(4):534–45.PubMedCrossRef
23.
Waller J, McCaffery K, Kitchener H, Nazroo J, Wardle J. Women’s experiences of repeated HPV testing in the context of cervical cancer screening: a qualitative study. Psychooncology. 2007;16(3):196–204.PubMedCrossRef
24.
McCaffery K, Waller J, Nazroo J, Wardle J. Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sex Transmit Infect. 2006;82(2):169–74.CrossRef
25.
Daley EM, Perrin KM, McDermott RJ, Vamos CA, Rayko HL, Packing-Ebuen JL, et al. The psychosocial burden of HPV: a mixed-method study of knowledge, attitudes and behaviors among HPV+ women. J Health Psychol. 2010;15(2):279–90.PubMedCrossRef
26.
Pourmohsen M, Simbar M, Nahidi F, Fakor F, Majd HA. Women’s experiences of infection with human papillomavirus in the face of disease symptoms: a qualitative study. Int J Womens Health Reprod Sci. 2020;8(1):37–45.CrossRef
27.
Kousha AMA, Maleki A, Najmi M, Dini M, Arjmandpour M. Package of essential non-communicable (PEN) disease interventions for primary health care in lran “IRAPEN”. Tehran: Mojassameh; 2017. p. 56.
28.
Bruni LB-RL, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. ICO information centre on HPV and cancer (HPV information centre). Hum Papillomavirus Relat Dis Iran. 2017.
29.
Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88.PubMedCrossRef
30.
Burnard P, Gill P, Stewart K, Treasure E, Chadwick B. Analysing and presenting qualitative data. Br Dent J. 2008;204(8):429.PubMedCrossRef
31.
Polit DF, Beck CT. Nursing research: generating and assessing evidence for nursing practice. Philadelphia: Lippincott Williams & Wilkins; 2008.
32.
Lincoln YS, Guba EG. But is it rigorous? Trustworthiness and authenticity in naturalistic evaluation. New Direct Program Eval. 1986;1986(30):73–84.CrossRef
33.
Graziottin A, Serafini A. HPV infection in women: psychosexual impact of genital warts and intraepithelial lesions. J Sex Med. 2009;6(3):633–45.PubMedCrossRef
34.
McRae J, Martin C, O'Leary J, Sharp L. “If you can't treat HPV, why test for it?” Women’s attitudes to the changing face of cervical cancer prevention: a focus group study. BMC Women’s Health. 2014;14:64.PubMedPubMedCentralCrossRef
35.
36.
37.
Tan J, Xiong YQ, He Q, Liu YM, Wang W, Chen M, et al. Peri-conceptional or pregnancy exposure of HPV vaccination and the risk of spontaneous abortion: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2019;19(1):302.PubMedPubMedCentralCrossRef
38.
Kyrgiou M, Mitra A, Arbyn M, Paraskevaidi M, Athanasiou A, Martin-Hirsch PP, et al. Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia. Cochrane Database Syst Rev. 2015;2015(9):008478.
39.
Daley EM, Marhefka SL, Buhi ER, Vamos CA, Hernandez ND, Giuliano AR. Human papillomavirus vaccine intentions among men participating in a human papillomavirus natural history study versus a comparison sample. Sex Transm Dis. 2010;37(10):644–52.PubMedPubMedCentralCrossRef
40.
Savoca S, Nardo LG, Rosano TF, D'Agosta S, Nardo F. CO(2) laser vaporization as primary therapy for human papillomavirus lesions. A prospective observational study. Acta Obstetr Gynecol Scand. 2001;80(12):1121–4.
41.
Lin H, Jeng C-J, Wang L-R. Psychological responses of women infected with cervical human papillomavirus: a qualitative study in Taiwan. Taiwan J Obstet Gynecol. 2011;50(2):154–8.PubMedCrossRef
42.
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.PubMedCrossRef
Metadata
Title
'Does HPV affect my fertility?' Reproductive concerns of HPV-positive women: a qualitative study
Authors
Kowsar Qaderi
Seyedeh Tahereh Mirmolaei
Mehrnaz Geranmayeh
Farnaz Farnam
Shahrzad Sheikh Hasani
Publication date
01-12-2021

Other articles of this Issue 1/2021

Reproductive Health 1/2021 Go to the issue

Research

Effect of COVID-19 pandemic on provision of sexual and reproductive health services in primary health facilities in Nigeria: a cross-sectional study

Research

Beliefs and misconceptions about contraception and condom use among adolescents in south-east Nigeria

Review

Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies

Research

A critical discourse analysis of adolescent fertility in Zambia: a postcolonial perspective

Research

Causes of short birth interval (kunika) in Bauchi State, Nigeria: systematizing local knowledge with fuzzy cognitive mapping

Research

Geographic variation and associated factors of long-acting contraceptive use among reproductive-age women in Ethiopia: a multi-level and spatial analysis of Ethiopian Demographic and Health Survey 2016 data